You are here: Industry Insights > Warfarin

News List

Takeda offloads $670M of European drugs as consumer health sale rumors resurface fiercepharma
April 26, 2020
Takeda has inked yet another deal aimed at lowering its debt level after the Shire acquisition.The Japanese pharma said Friday that is has agreed to sell about 110 over-the-counter and prescription drugs in Europe, as well as two manufacturing sites, to D
Do You Take Warfarin? Time of Day Might Not Matter drugs
January 19, 2020
Patients taking the blood thinner warfarin have been told that it should be taken at night, but a new study found the time of day doesn't matter.
For Men, Living Alone May Mean Poorer Control of Blood-Thinning Meds drugs
September 03, 2019
Men who are on the blood-thinning drug warfarin have more difficulty taking the medication if they live alone, but the same is not true for women, a new study finds.
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive fiercepharma
August 01, 2018
Last year, Pfizer and Bristol-Myers Squibb’s Eliquis replaced Johnson & Johnson’s Xarelto as the leader of the novel oral anticoagulant class. And now it’s about to unseat an even bigger foe: warfarin.
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive fiercepharma
July 31, 2018
Last year, Pfizer and Bristol-Myers Squibb’s Eliquis replaced Johnson & Johnson’s Xarelto as the leader of the novel oral anticoagulant class. And now it’s about to unseat an even bigger foe: warfarin.
New anti-clotting drugs linked to lower risk of serious bleeding europeanpharmaceuticalreview
July 06, 2018
Direct oral anticoagulants (DOACs) used to treat serious blood clots are associated with reduced risks of major bleeding compared with the older anti-clotting drug, warfarin, finds a new study.
DOACs used as a alternative to warfarin to treat venous thromboembolism europeanpharmaceuticalreview
October 18, 2017
A study has found that a new group of drugs used to treat patients with serious blood clots are not associated with a higher risk of major bleeding compared with warfarin…
Uninterrupted Pradaxa showed less major bleeding than warfarin in atrial fibrillation patients cphi-online
March 22, 2017
Patients studied in the trial were reflective of those undergoing catheter ablation in routine clinical practice, providing highly relevant data to treating physicians.
Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin cphi-online
February 28, 2017
Compared with warfarin, Pradaxa was associated with a 26% reduced risk of stroke and a 20% reduced risk of major bleeding.